awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q50545401-14E37CF7-31A8-47CA-A1D8-C447D2B89655
Q50545401-14E37CF7-31A8-47CA-A1D8-C447D2B89655
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50545401-14E37CF7-31A8-47CA-A1D8-C447D2B89655
Two immune-enhanced molecular subtypes differ in inflammation, checkpoint signaling and outcome of advanced head and neck squamous cell carcinoma.
P2860
Q50545401-14E37CF7-31A8-47CA-A1D8-C447D2B89655
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50545401-14E37CF7-31A8-47CA-A1D8-C447D2B89655
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e4df2cda32ad1b5e1028b6fa23bd4d09084c2c8d
P2860
Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study.